Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
The present invention relates to nucleic acid molecules which modulate the
synthesis, expression and/or stability of an mRNA encoding one or more
receptors of vascular endothelial growth factor.